Design of a PET-isotope-based hadron therapy facility

Slides:



Advertisements
Similar presentations
Heavy Ion Cancer Therapy
Advertisements

MedAustron – Austrian Hadron Therapy Centre
ISIS Accelerator Division
Experience, Expertise and a Commitment to Excellence™
An Advanced Linear Accelerator Facility for Microelectronic Dose Rate Studies P.E. Sokol and S.Y.Lee Indiana University.
Mass Spectroscopy Mass Spectrometry ä Most useful tool for molecular structure determination if you can get it into gas phase ä Molecular weight of.
Design and test of a high-speed beam monitor for hardon therapy H. Pernegger on behalf of Erich Griesmayer Fachhochschule Wr. Neustadt/Fotec Austria (H.
Diagnostics for Medical Accelerators
A (Quick) Survey of (Some) Medical Accelerators Dr. Todd Satogata Brookhaven National Laboratory SUNY Stony Brook PHY 684 – September 5, 2007  The NASA.
Carbon therapy machine Working group2 FFAG workshop 2003 at KEK.
Carbon Injector for FFAG
Noyaux CERN- ISOLDE Yorick Blumenfeld.
P. Spiller, SIS18upgrade, Peter Spiller GSI, Darmstadt Kick off Meeting - EU Construction DIRAC Phase SIS18 upgrade.
MedAustron Dr. Peter Urschütz, EBG MedAustron GmbH
A U.S. Department of Energy Office of Science Laboratory Operated by The University of Chicago Argonne National Laboratory Office of Science U.S. Department.
Radioactive ion beam facilities How does they work ? 2012 Student Practice in JINR Fields of Research 9.oct.2012 I. Sivacekflerovlab.jinr.ru.
Cancer Therapy and Imaging Cancer Therapy and Imaging Rob Edgecock STFC Rutherford Appleton Laboratory.
CERN Medical Applications Steve Myers Head of CERN Medical Applications Former Director of Accelerators and Technology CERN, Geneva.
J-PARC Accelerators Masahito Tomizawa KEK Acc. Lab. Outline, Status, Schedule of J-PARC accelerator MR Beam Power Upgrade.
Heavy Ion Accelerators for RIKEN RI Beam Factory and Upgrade Plans H. Okuno, et. al. (RIKEN Nishina Center) and P. Ostroumov (ANL) Upgrade Injector Low.
January 5, 2004S. A. Pande - CAT-KEK School on SNS MeV Injector Linac for Indian Spallation Neutron Source S. A. PANDE.
Mats Lindroos Future R&D: beta-beam Mats Lindroos.
EBIS ARR Jim Alessi May 4- 7, 2010 Technical Overview.
PROTON LINAC FOR INDIAN SNS Vinod Bharadwaj, SLAC (reporting for the Indian SNS Design Team)
Radioactive Ion Beams CW 0.5 MW (for protons) 1 GeV (for protons) p to U Chiara, Manuel, Adam, HuiMay 2011, CAS, Bilbao.
Polarized source upgrade. Source upgrade project Main component delivery: Atomic Beam Source- August 2011 Superconducting solenoid- March-2012.
New Gantry Idea for H + /C 6+ Therapy G H Rees, ASTeC, RAL 4 th September, 2008.
Polarized source upgrade RSC, January 11, OPPIS LINAC Booster AGS RHIC ( ) ∙10 11 p/bunch 0.6mA x 300us→11∙10 11 polarized H - /pulse. ( )
On behalf of the whole MedAustron Therapy Accelerator Division
The International Workshop on Thin Films. Padova 9-12 Oct of slides Present Status of the World- wide Fusion Programme and possible applications.
Proton Driver Design Keith Gollwitzer Fermilab February 19, 2014.
T. Fleck, GSI, Darmstadt, Germany ICALEPCS Status of the Control System for HICAT at an advanced stage of Commissioning Functions, Restrictions.
Development of a superconducting rotating-gantry for carbon therapy
Hartmut Eickhoff, GSI 1 Developments in Hadrontherapy -the role of Basic Research Institutes H. Eickhoff GSI/Darmstadt.
Proton Driver Keith Gollwitzer Accelerator Division Fermilab MAP Collaboration Meeting June 20, 2013.
ADSR Inst.July 2009 From PAMELA to ADSR, T.Yokoi From PAMELA to ADSR Takeichiro Yokoi (JAI)
The Australian Hadron Therapy and Research Facility.
Beam Preparation, Task 9 Department of Physics, University of Jyväskylä.
Development of Cryogenic Moderators Using a Small Proton Accelerator Yoshiaki Kiyanagi*, Fujio Hiraga, Takashi Kamiyama, Akira Homma, Fumiyuki Fujita and.
Koichi MurakamiGeant4 Physics Verification and Validation (17-19/Jul./2006) 1 Results from the recent carbon test beam at HIMAC Koichi Murakami Statoru.
Neutrino Factory by Zunbeltz, Davide, Margarita, Wolfgang IDS proposal.
A Compact FFAG for Radioisotope Production D. Bruton R. Barlow, R. Edgecock, and C.J. Johnstone.
0 Ion Beam Facilities at KOMAC Chan Young Lee on behalf of KOMAC Chan Young Lee on behalf of KOMAC ICABU2014, November 12~14,
High intensity electron beam and infrastructure Paolo Valente * INFN Roma * On behalf of the BTF and LINAC staff.
MLL Workshop on Future Science 2019 and beyond, 16.Dec.2015 The accelerator, as seen by.. 1 From LBNL Image Library Collection by Dave Judd and Ronn MacKenzie.
Plans and Activities at CERN
Precision Tests of Fundamental Interactions with Ion Trap Experiments
Lecture at the MEDICIS-PROMED Summer School
Present and possible future schemes for hadron therapy linacs Alberto Degiovanni for the ADAM team HG2017 Workshop , Valencia.
Progress in the Application
A. Martynov on behalf of accelerator division.
Improvement of beam current in KIRAMS-13 using upgrade of
Progress in the Multi-Ion Injector Linac Design
Accelerator layout > 1000 components (almost 300 magnets and power converters, 153 beam diagnostic devices, about 400m of vacuum pipes, a not neglectable.
Johannes Leidner, Fabrizio Murtas, Marco Silari
Status of the beta-beam study
of secondary light ion beams
How to run ions in the future?
Future R&D: beta-beam Mats Lindroos Mats Lindroos.
Beam dynamics of RAON accelerator system
Mass Spectroscopy. Mass Spectroscopy Mass Spectrometry Most useful tool for molecular structure determination if you can get it into gas phase Molecular.
EffiCAS Efficient Facility for Ions at CAS
FFAG Accelerator Proton Driver for Neutrino Factory
A summary of world-wide test beam facilities
Progress towards Pulsed Multi-MW CERN Proton Drivers
Physics Design on Injector I
Multi-Ion Injector Linac Design – Progress Summary
Some Thoughts on the JLEIC Ion Injector
Optimization of JLEIC Integrated Luminosity Without On-Energy Cooling*
Choice of harmonic number with the consideration of ion beam formation
Presentation transcript:

Design of a PET-isotope-based hadron therapy facility L. Penescu Workshop at the MEDICIS-PROMED Summer School 4-11 June 2017, Fondazione CNAO

Summary 12C treatment specifications Existing Carbon facilities Challenges for 11C treatment Workshop methodology Fun L. Penescu KI001_IK_201706052

12C treatment specifications SPILLS: 0.1 to 10 seconds ENERGIES: C6+: 120 to 400 MeV/u Energies corresponding to 3-37 cm penetration depth in human tissue ~1 minute to deliver 2 Gray in 1 L tumor volume INTENSITIES: C6+: 4·108 particles/spill (4 intensity steps for each beam species) BEAM SIZES: 4 to 10mm (4 intensity steps) H+: 60 to 250 MeV/u H+: 1·1010 particles/spill Spill formation: defined in the synchrotron Duration. Intensity uniformity. Position uniformity. Spot formation: defined in the HEBT line Spot size Position at isocenter Restrictions on injector: not critical Most of the injected beam limitations can be corrected in the synchrotron QA VERIFICATION (at irradiation room) TOLERANCE LEVEL Position ± 0.5mm Size (FWHM) MAX {±1.0mm; ±10%} Intensity ±30 % L. Penescu KI001_IK_201706052

Existing Carbon facilities HIT MedAustron HIMAC CNAO L. Penescu KI001_IK_201706052

Operation scheme - MedAustron SOURCE LEBT LINAC SYNCHROTRON INJECTION Multi-turn injection 16 turns Gas: CO2 +He Energy: 8KeV/u Energy: 7MeV/u t[1;450] 2 2 200A t0 (continuous) t t(s) t(s) Extraction (El. field) Separation (Mg. field) Acceleration (RF) Bunching (RF) Chopping (electrostatic) Stripping (foil) (C4+ → C6+) IRRADIATION ROOM HEBT SYNCHROTRON STAGES Center position Intensity (t) FWHM RF capture Acceleration Resonant (slow) extraction Spill formation Transverse scanning Slice “painting”, E Spill transport L. Penescu KI001_IK_201706052

Challenges for 11C treatment Design recipe: Challenges for 11C Production Accumulation Acceleration Delivery PRODUCTION ACCUMULATION Options for PRODUCTION Options for ACCUMULATION Secondary challenges: irradiation time vs. resolution of PET scan Stability… Batch releases 11C molecule to ion source ISOL production In-flight production Fragmentation (e.g. 12C beam on 7Be target) Fusion-evaporation (low beam energy) Batch containing supply atoms 1+ ions accumulated in a trap 6+ ions accumulated in a ring L. Penescu KI001_IK_201706052

Design baseline A B Use of compact PET cyclotron 10–20 MeV protons 30 GBq batches can be produced every 30 min Reaction: 14N(p,)11C in high pressure N2 targets Ion source: ECR A 31010 11CO2/s 1108 11CO2/s Validation location: existing 12C therapy facility Use of ISOL production scheme Spallation reactions 19F(p,X)11C and 23Na(p,X)11C Use commercial cyclotron: 70 MeV, 1.2 mA beam Target: molten fluoride, made of a NaF:LiF eutectic Ion source: VADIS B 5% ionization efficiency, 45% for transport and trapping, 16.2% for injection into the synchrotron 41011 11CO2/s 1.5108 11CO2/s Validation location: existing ISOL facility L. Penescu KI001_IK_201706052

Workshop methodology Information structure “DOMINO model” for all components Acceptance Performance Output Min/max values Charge state Intensity Time Energy Efficiency Time structure Operation steps (Operation modes) Limitations Risks SPARK: We have experts among us! GAS: The “stupid questions” are welcome! L. Penescu KI001_IK_201706052

First line of experts Simon  Production and mass separation of 11CO+ Annie  Molecular breakup in RFQ cooler Johanna  Charge breeding scheme KyungDon  Treatment planning for 11C L. Penescu KI001_IK_201706052

Advanced considerations Quality assurance of the design: Reliability of the used numbers; Constraints related to safety, vacuum, performance stability, measurement precision, operation Resource redundancy Quality assurance of the performance: Important points to monitor Stability and reproducibility The accelerator is able to generate: Number of different energies: 255 Number of beam sizes: 4 Number of intensities: 4 Number of extraction times: 8 Beam combinations per beam line: 32640 Are we happy with the 11C?... And with the baseline? L. Penescu KI001_IK_201706052